GSK (GSK) News Today $40.91 +0.24 (+0.59%) Closing price 03:59 PM EasternExtended Trading$41.63 +0.72 (+1.76%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period FDA approves drug that Trump due to suggest as autism treatment1 hour ago | reuters.comGSK spin-off Haleon eyes Tylenol takeoverSeptember 20 at 11:02 PM | msn.comGSK PLC Sponsored ADR $GSK Stock Holdings Lifted by Miller Howard Investments Inc. NYSeptember 20 at 6:40 AM | marketbeat.comEmma Walmsley’s impatient overhaul of GSKSeptember 19 at 8:46 AM | finance.yahoo.comGSK Just Dropped $30 Billion on America's Biotech Future--Here's What That BuysSeptember 18, 2025 | finance.yahoo.comFirst Bank & Trust Takes $1.22 Million Position in GSK PLC Sponsored ADR $GSKSeptember 17, 2025 | marketbeat.comBritain's GSK Vows $30 Bn Investment In US As Trump VisitsSeptember 17, 2025 | barrons.comGSK unveils $30B U.S. investment after Trump arrives in U.K. for state visitSeptember 17, 2025 | msn.comGSK commits $30 billion to US research and development, factory expansion, as Trump visits UKSeptember 17, 2025 | msn.comUK's GSK announces $30 billion U.S. pharma investment amid Trump state visitSeptember 17, 2025 | cnbc.comRep. Lisa C. McClain Buys GSK PLC Sponsored ADR (NYSE:GSK) SharesSeptember 17, 2025 | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Receives $37.38 Average Target Price from AnalystsSeptember 17, 2025 | americanbankingnews.comGSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In AmericaSeptember 16, 2025 | msn.comGSK Pledges $30 Billion of US Investment as Trump Arrives in UKSeptember 16, 2025 | msn.comGSK and Eli Lilly are the latest multinational drugmakers to unveil plans to build more U.S. manufacturing plants and other operations, moves aimed partly at mitigating the threat of tariffsSeptember 16, 2025 | wsj.comGSK plans $30 billion US investment as pharma tariff threat loomsSeptember 16, 2025 | reuters.comGSK Says It Will Spend $30B on U.S. Manufacturing and R&DSeptember 16, 2025 | barrons.comGSK invests £22bn in the US to coincide with Donald Trump's state visitSeptember 16, 2025 | msn.comBard Financial Services Inc. Buys 12,500 Shares of GSK PLC Sponsored ADR $GSKSeptember 16, 2025 | marketbeat.comDouglas Lane & Associates LLC Has $50.58 Million Stock Holdings in GSK PLC Sponsored ADR $GSKSeptember 16, 2025 | marketbeat.comGSK falls Monday, underperforms marketSeptember 15, 2025 | marketwatch.comGSK PLC Sponsored ADR (NYSE:GSK) Given Consensus Recommendation of "Reduce" by BrokeragesSeptember 15, 2025 | marketbeat.comFirst Hawaiian Bank Raises Position in GSK PLC Sponsored ADR $GSKSeptember 14, 2025 | marketbeat.comRep. Robert B. Aderholt Sells GSK PLC Sponsored ADR (NYSE:GSK) StockSeptember 14, 2025 | marketbeat.comChelsea Counsel Co. Sells 20,000 Shares of GSK PLC Sponsored ADR $GSKSeptember 12, 2025 | marketbeat.comAcadian Asset Management LLC Purchases 2,663,270 Shares of GSK PLC Sponsored ADR $GSKSeptember 12, 2025 | marketbeat.comGSK PLC Sponsored ADR $GSK Shares Bought by Fred Alger Management LLCSeptember 12, 2025 | marketbeat.comNewEdge Advisors LLC Raises Stock Holdings in GSK PLC Sponsored ADR $GSKSeptember 12, 2025 | marketbeat.comKepler Capital Maintains a Hold Rating on GSK plc (GSK)September 11, 2025 | msn.comGSK Enhances Shareholder Value with Continued Share BuybackSeptember 11, 2025 | msn.comGSK PLC Sponsored ADR $GSK Stake Boosted by Everstar Asset Management LLCSeptember 10, 2025 | marketbeat.comAncora Advisors LLC Sells 9,805 Shares of GSK PLC Sponsored ADR $GSKSeptember 9, 2025 | marketbeat.comWhat is Zacks Research's Estimate for GSK FY2026 Earnings?September 7, 2025 | marketbeat.comNational Wealth Management Group LLC Takes $413,000 Position in GSK PLC Sponsored ADR $GSKSeptember 7, 2025 | marketbeat.comAprio Wealth Management LLC Buys Shares of 6,397 GSK PLC Sponsored ADR $GSKSeptember 7, 2025 | marketbeat.comClark Capital Management Group Inc. Has $60.66 Million Stake in GSK PLC Sponsored ADR $GSKSeptember 6, 2025 | marketbeat.comWhat is Zacks Research's Forecast for GSK Q1 Earnings?September 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Purchases New Position in GSK PLC Sponsored ADR $GSKSeptember 6, 2025 | marketbeat.comVident Advisory LLC Boosts Stock Holdings in GSK PLC Sponsored ADR $GSKSeptember 6, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSKSeptember 3, 2025 | prnewswire.comGSK PLC Sponsored ADR $GSK Stock Holdings Increased by Royal Bank of CanadaSeptember 3, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Trims Position in GSK PLC Sponsored ADR $GSKSeptember 3, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSKSeptember 2, 2025 | globenewswire.comArmistice Capital LLC Has $14.64 Million Stake in GSK PLC Sponsored ADR $GSKSeptember 2, 2025 | marketbeat.comKestra Advisory Services LLC Has $1.33 Million Stake in GSK PLC Sponsored ADR $GSKSeptember 2, 2025 | marketbeat.comNuveen LLC Invests $1.46 Million in GSK PLC Sponsored ADR $GSKSeptember 2, 2025 | marketbeat.com76,100 Shares in GSK PLC Sponsored ADR $GSK Purchased by OMERS ADMINISTRATION CorpSeptember 1, 2025 | marketbeat.comGSK PLC Sponsored ADR $GSK Shares Purchased by Northwestern Mutual Wealth Management Co.August 31, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSKAugust 29, 2025 | globenewswire.comGSK PLC Sponsored ADR $GSK Shares Sold by Callodine Capital Management LPAugust 29, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.480.73▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼2021▲GSK Articles Average Week Get the Latest News and Ratings for GSK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for GSK and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Novartis News Today Novo Nordisk A/S News Today AstraZeneca News Today Sanofi News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredThe next AI Hype Spike is days away — don’t miss itOn this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
